Diagnosis of PF-ILD involves a combination of clinical performance, imaging, laboratory testing, and pathological evaluation; it can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of PF-ILD involves the development of personalized treatment plans, typically including drug therapy, rehabilitation, regular follow-up, and multi-dimensional management. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine diseases have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the risk of death associated with PF-ILD. The platform serves a team of domestic and international experts in the field of infectious respiratory digestive endocrine systems in China, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of changes in conditions and treatment effects.